|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Synergetics, Inc., a privately-held manufacturer of durable and disposable instruments for use in retina surgery, neurosurgery and other microsurgery markets. |
|---|---|
| Transferring Party | Valley Forge Scientific Corp. (Nasdaq: VLFG), a manufacturer of bipolar electrosurgical systems and related instrumentation. |
| Sector | Medical Devices |
| Date | May 3, 2005 |
| Analysis In this stock for stock merger, Synergetics ends up with 66% of the combined company. Valley Forge's sales are only $4.8m, while Synergetics' were $16.9m. Deal value is - $30.4m , but in the combined company's stock. Combines Synegetic's presence in retina surgery, neurosurgery, microsurgery and medical instruments with Vally Forge's electrosurgery offerings. Marries Synergetics capabilities in disposables with Valley Forge's electro-surgery competence, while widening sales channels for the combined company. Deal value -- $30.4m on sales of $4.8m (6.3x) sales, but Valley Forge was public. As of Oct 07, sales wer $48m and market cap $73. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |